In accordance with the qPCR findings, the WB analyses demonstrated a notable elevation in the protein levels of CCL5, CCR5, and CYP1A1 within the cancer tissues after combination therapy (Figure 5G,H). The gene discussed is CCR5; the disease is cancer.